Cargando…

Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State

BACKGROUND: Measles remains the leading cause of vaccine-preventable childhood mortality in developing countries, with its greatest incidence in children younger than 2 years of age. The aim of this study was to determine the seroprevalence of measles virus in children (aged 0–8 months) and older ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Olaitan, AE, Ella, EE, Ameh, JB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362903/
https://www.ncbi.nlm.nih.gov/pubmed/25792852
http://dx.doi.org/10.2147/IJGM.S79423
_version_ 1782361855088394240
author Olaitan, AE
Ella, EE
Ameh, JB
author_facet Olaitan, AE
Ella, EE
Ameh, JB
author_sort Olaitan, AE
collection PubMed
description BACKGROUND: Measles remains the leading cause of vaccine-preventable childhood mortality in developing countries, with its greatest incidence in children younger than 2 years of age. The aim of this study was to determine the seroprevalence of measles virus in children (aged 0–8 months) and older children (aged 9–23 months) presenting with measles-like symptoms. METHODS: A total of 273 blood samples comprising 200 from children aged 0–8 months and 73 from children aged 9–23 months were collected and analyzed for measles virus IgM antibodies by enzyme-linked immunosorbent assay. RESULTS: An overall prevalence of 21.2% was obtained, with a prevalence of 6.5% in children aged 0–8 months and 61.6% in children aged 9–23 months. The prevalence of measles virus increased with age in children aged 0–8 months and decreased with age in older children (aged 9–23 months), showing a significant association between measles virus and age of the child (P=0.000). A higher prevalence was found in females (27.5%) than in males (16.3%) and this difference was significant (odds ratio 1.942, P=0.025). There was no significant association with the level of parental education, parental occupation, or number of children in the family (P>0.05). With respect to children’s vaccination status and breastfeeding, there was a significant association (P<0.05). The marital status of the family, place of residence, and household size showed no significant association with the prevalence of measles virus. However, a significant association was observed in relation to maternal measles history (odds ratio 2.535, P=0.005) and maternal vaccination status (odds ratio 1.791, P=0.049), as well as between measles virus infection and all presenting symptoms, except for vomiting, malaria, typhoid, and pneumonia, which showed no significant association (P>0.05). CONCLUSION: The findings of this study confirm the presence of measles virus infection in children aged 0–8 months.
format Online
Article
Text
id pubmed-4362903
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43629032015-03-19 Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State Olaitan, AE Ella, EE Ameh, JB Int J Gen Med Original Research BACKGROUND: Measles remains the leading cause of vaccine-preventable childhood mortality in developing countries, with its greatest incidence in children younger than 2 years of age. The aim of this study was to determine the seroprevalence of measles virus in children (aged 0–8 months) and older children (aged 9–23 months) presenting with measles-like symptoms. METHODS: A total of 273 blood samples comprising 200 from children aged 0–8 months and 73 from children aged 9–23 months were collected and analyzed for measles virus IgM antibodies by enzyme-linked immunosorbent assay. RESULTS: An overall prevalence of 21.2% was obtained, with a prevalence of 6.5% in children aged 0–8 months and 61.6% in children aged 9–23 months. The prevalence of measles virus increased with age in children aged 0–8 months and decreased with age in older children (aged 9–23 months), showing a significant association between measles virus and age of the child (P=0.000). A higher prevalence was found in females (27.5%) than in males (16.3%) and this difference was significant (odds ratio 1.942, P=0.025). There was no significant association with the level of parental education, parental occupation, or number of children in the family (P>0.05). With respect to children’s vaccination status and breastfeeding, there was a significant association (P<0.05). The marital status of the family, place of residence, and household size showed no significant association with the prevalence of measles virus. However, a significant association was observed in relation to maternal measles history (odds ratio 2.535, P=0.005) and maternal vaccination status (odds ratio 1.791, P=0.049), as well as between measles virus infection and all presenting symptoms, except for vomiting, malaria, typhoid, and pneumonia, which showed no significant association (P>0.05). CONCLUSION: The findings of this study confirm the presence of measles virus infection in children aged 0–8 months. Dove Medical Press 2015-03-10 /pmc/articles/PMC4362903/ /pubmed/25792852 http://dx.doi.org/10.2147/IJGM.S79423 Text en © 2015 Olaitan et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Olaitan, AE
Ella, EE
Ameh, JB
Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State
title Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State
title_full Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State
title_fullStr Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State
title_full_unstemmed Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State
title_short Comparative seroprevalence of measles virus immunoglobulin M antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in Kaduna State
title_sort comparative seroprevalence of measles virus immunoglobulin m antibodies in children aged 0–8 months and a control population aged 9–23 months presenting with measles-like symptoms in selected hospitals in kaduna state
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362903/
https://www.ncbi.nlm.nih.gov/pubmed/25792852
http://dx.doi.org/10.2147/IJGM.S79423
work_keys_str_mv AT olaitanae comparativeseroprevalenceofmeaslesvirusimmunoglobulinmantibodiesinchildrenaged08monthsandacontrolpopulationaged923monthspresentingwithmeasleslikesymptomsinselectedhospitalsinkadunastate
AT ellaee comparativeseroprevalenceofmeaslesvirusimmunoglobulinmantibodiesinchildrenaged08monthsandacontrolpopulationaged923monthspresentingwithmeasleslikesymptomsinselectedhospitalsinkadunastate
AT amehjb comparativeseroprevalenceofmeaslesvirusimmunoglobulinmantibodiesinchildrenaged08monthsandacontrolpopulationaged923monthspresentingwithmeasleslikesymptomsinselectedhospitalsinkadunastate